Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance - Müller, E.E.
125,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Gebundenes Buch

The book describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to
exert a direct anti-neoplastic activity or to potentiate the activity of
traditional chemotherapeutic agents on neuroendocrine and solid tumors. In
addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with
important endocrine and extra-endcocrine action, is presented. Therefore,
in addition to traditional chemotherapy, characterized by high toxicity and
non-selective action on tumoral cells, the reader can find a…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The book describes the ability of a series of endocrine-derived compounds,
i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to

exert a direct anti-neoplastic activity or to potentiate the activity of

traditional chemotherapeutic agents on neuroendocrine and solid tumors. In

addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with

important endocrine and extra-endcocrine action, is presented. Therefore,

in addition to traditional chemotherapy, characterized by high toxicity and

non-selective action on tumoral cells, the reader can find a new approach

with more selective, less cytotoxic endocrine derived compounds TOC:
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Eugenio E. Müller, University of Milano, Italy